ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000319.1|Cephamycin_1 # 1 # 594 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.741	BGC0000319.1|Cephamycin_1 	1	594	+	Loose	500	234.958	blaC	65.22	3007182	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam; penem	antibiotic inactivation	class A Mycobacterium tuberculosis bla beta-lactamase	CACATCGCCACCGGGCTGACGGTCGGCCAGCTCTGTGACGCCGCCATCCGGCACAGCGACGGCACGGCCGGGAATCTGCTGATGCGCGATCTCGGCGGGCCCTCCCGGCTCACCGCCTATCTGCGCGGACTCGGGGACTCCGTCAGCCGGATGGACCAGTACGAGCCCGAGCTGAACCACGACCCGCCGCACGACCCCCGGGACACCACCACCCCCCGGGCGATCGCGTCCGACTACCGGAAGCTGGTCCTCGGGGACGCGCTGACCCCGGACCGGCGCGCCCTGCTCACCGACTGGCTGGTGCGGAACACCACCGGAGGCCGCCGTATCCGGGCCGGAGTCCCCTCCGGCTGGCGGGTGGCCGACAAGACCGGAACCGGCAACTACGGCAGGGCCAACGACATCGCCGTGCTCTGGCCGCCCCGGTCGTCCCCGCTGGTAGTAGCCGTCATGTCCGACCGTCCCGGCTTTCGCACCCCGCCCAGCGAACGGCTGATCGCCGAGGCCGCGGAGCGGATCGTCGCCGGGCTGGTCCGGCACCCGCCGACCCATGCGTCAGGGGCCGGGGCGCCCTCGCGGCACCCCGGCCCCTGA	HIATGLTVGQLCDAAIRHSDGTAGNLLMRDLGGPSRLTAYLRGLGDSVSRMDQYEPELNHDPPHDPRDTTTPRAIASDYRKLVLGDALTPDRRALLTDWLVRNTTGGRRIRAGVPSGWRVADKTGTGNYGRANDIAVLWPPRSSPLVVAVMSDRPGFRTPPSERLIAEAAERIVAGLVRHPPTHASGAGAPSRHPGP	MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLGVYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPVAQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDAEEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAGFPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAATCVAGVLA	64.17	gnl|BL_ORD_ID|4814|hsp_num:0	5800			369	918	cefoxitin; amoxicillin; cefalotin; temocillin; ticarcillin
BGC0000319.1|Cephamycin_2 # 631 # 2712 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.716	BGC0000319.1|Cephamycin_2 	631	2712	-	Loose	575	35.039	AST-1	27.59	3004740	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	AST Beta-lactamase	ATGGCGGGGCGGTCCCCCGACACACTCGACCAGAAGAACGTGCCGACGGGGAACGACGGCGACGAACGCGATCCGCGCCCGGCCGACGAGGGGACGACCTCACCGGCCACCGACGAGGTGCCGCCCCGGAGCGAGGACGCGGACGACGAGACGGGGGCCGACGACGAGACGGTGGACGCCGAGTCCGCCGAGTCCGCCGAGGGCACAGAGGGGTCGGAAAAGGCTGAGGAGGCGGAGACTCCGGCTGACGAGAAGCCGGAGTCCGCCGTTCCCGGGCCCAAGGAGCCGAAGCCGGAGCCGGAGCCGGAGGCCACGGCCGAGCCCGCGAAGCCCGCCGAGTCCTCGGAGACCACGCGGGTGATCGCGCTGCCGCGCACGGGCACGGACCGCACGGGCACGGACGGGAAGGACGCGGACCCGACCTCGGACGCTCCCGTTCCGGACGACGCCACCCGCAGTCTGCGCAAGCCGCGCCCGTCCTGGGCCGTGGACCCGGACGCGCCCGCGAAGCCCGTGCCCACGCCGCGGGAGCAGACACCGGAGCAGGCACAGAAGCAGGCACAGAAGCAGGCACAGAAGCAGGCCCCGGAGCGGGACAGGACACCGGAGCGGGACAAGGCCCCGAAGCCGAAGCCCGTACCGGAGCCGAAGCCTGCCCGGACACCCGCCGCCGCGTCGGCGCCGGACGCGGCCTCGGACGCGGCACTGGTCCAGCGGCAGCGGCAGGAGCAGACCCGGAAGCGGGAGCAGGAACGGGAGGACGCCCGCGCGCGGCTCGATCTGCTCGCCCGGCTCTCCGTCCCCGCCGGGTCGTCCGCCGCCCCCCGCTCCCGTGGCCGCGCCCGCCTGGCCATGATCGCGATCCCGCTGGCGGCGCTGCTGCTCGTCATCGCCTTCGTCGCCGTCCAACTCCTGCGCCCGCTCCCGGACCCGGTCCTCACCCTGCGCGACAGCGCCTCGTCCACCACGCTCGGCGGGGACCGGATCTCCATACCCTGGCCCAAGGAGGGACAGGGCGCGGTCACCGTCGCGGGCTCCGGCGTCTACGAGACCTTCGGCCCGGAGAAGTCCGTACCGACGGCGAGCACCGCCAAGATCATGACGGCCTATGTGCTGCTGCGGAAGCACCCCCTCAAGCGGGGCGAACCCGGGCCGACCATCACGGTCGACGCGCAGACCGTGGCGGAGGGCAAGGCCAAGGACGAGTCCCGGATCGAGGGACTCACGGAGGGTCAGACCTTCAGCCAGCAGGACATGCTGAAGATGCTGATGATCCCGTCCGGCAACAACATAGGGCGGCTGCTGGCCCGCTGGTCCACCAAGACGGACGATCAGACGGCGTTCGTCCGGGAGATGAACGAGGCCGCGAAGGACCTCGGCATGAAGAACACCGTCTACACCGACCCCAGCGGCCTGGACAAGGGGACGGTCAGCACCGCCGTCGACCAGCTCAAGCTGGCCGAGGCGGTCATGGAGTACGACGTCTTCCGCGATGTCGTCGCCCTGCCGAACGCCGAGATCCCCGGCCACGGCCGGATCTACAACAACAACGACCGGCTGATACTGGCCGGTCTGGGGATCGTGGGCATCAAGACCGGCTCCAACACCCCCGCGGGCGGCACGCTGTCCTGGGCCGCGTACAAGACGTTCGACGGCGAGGACCGGCTGATCCTGGGCACGATGATGGCCCAGCACGCCCCGGGGCCCGACATCAACGGCGGCGACAGCCTGGTGCTGGTGCAGGACAACAGCAGGAAGGTCGTCGCCTCGGTGCGCGAGATGCTGACCTCCGCGAACGTGGTGAAGAAGGGCGAGGTCGTCGGCCATGTCGACGACCGCTTCGGCCGCCGGATCCCGGTGGTGACGACCAAGTCCCTCGATCTGGTCGGCCTGTCCGGTCAGAAGGTGACGCTGACCTACGGCCGCAAGGGCGACGGAGCCCTCTCGCGCACGGCGAGGGCCGGGGCCGTGGTCGGTGAGCTGACGGTGGGGAACGGTCCCGACGCGCACCGGATTCCGCTGGCCCTCAAGGAGGGGCTGACGGAGCCGTCCCTGGGCACCAGGCTGACCCGGCTCGGCTGA	MAGRSPDTLDQKNVPTGNDGDERDPRPADEGTTSPATDEVPPRSEDADDETGADDETVDAESAESAEGTEGSEKAEEAETPADEKPESAVPGPKEPKPEPEPEATAEPAKPAESSETTRVIALPRTGTDRTGTDGKDADPTSDAPVPDDATRSLRKPRPSWAVDPDAPAKPVPTPREQTPEQAQKQAQKQAQKQAPERDRTPERDKAPKPKPVPEPKPARTPAAASAPDAASDAALVQRQRQEQTRKREQEREDARARLDLLARLSVPAGSSAAPRSRGRARLAMIAIPLAALLLVIAFVAVQLLRPLPDPVLTLRDSASSTTLGGDRISIPWPKEGQGAVTVAGSGVYETFGPEKSVPTASTAKIMTAYVLLRKHPLKRGEPGPTITVDAQTVAEGKAKDESRIEGLTEGQTFSQQDMLKMLMIPSGNNIGRLLARWSTKTDDQTAFVREMNEAAKDLGMKNTVYTDPSGLDKGTVSTAVDQLKLAEAVMEYDVFRDVVALPNAEIPGHGRIYNNNDRLILAGLGIVGIKTGSNTPAGGTLSWAAYKTFDGEDRLILGTMMAQHAPGPDINGGDSLVLVQDNSRKVVASVREMLTSANVVKKGEVVGHVDDRFGRRIPVVTTKSLDLVGLSGQKVTLTYGRKGDGALSRTARAGAVVGELTVGNGPDAHRIPLALKEGLTEPSLGTRLTRLG	MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELETTSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSAAELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDATSRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGATRIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAEATRVVVDALG	223.55	gnl|BL_ORD_ID|2556|hsp_num:0	3555			219	549	
BGC0000319.1|Cephamycin_3 # 3066 # 4535 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.744	BGC0000319.1|Cephamycin_3 	3066	4535	-	Loose	1000	177.563	efpA	37.2	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGAGGGAGTTCCGCTGCGAGGACGGCGCTCGCGCTGTCGTGTACGACGCACTTCCTGGTCCTGTTCGACGTCTCGGTGATGACCGTGGCGCTGCCGTCGATCCAGTCCGACCTGGGGTTCACCCCCTCCGGCCTCCAATGGGTCGTCAGCGCCTACACCCTGGCCTTCGCCGGACTGCTGCTGCTCGGCGGACGCCTGGCCGACCTGTACGGACACCGCAGGGTCTTCACGGCGGGCCTCGCCGTCTTCACCGTCGCCAGCCTGCTCGGCGGGCTCGCGACCGACCCGGCGACCCTCATCGCGGCCCGGGCCGCACAGGGCCTCGGCGCCGCCGTCCTCGCCCCCCTGTCGCTGACCATGCTGACGACCAGCTTCCCCGAGGGCCCCAGCCGTACCAGGGCCCTGACCATCTGGACCGCGGTGGCCCTGGCCGGCGGAGCGGCGGGCAATCTGCTCGGCGGGCTGCTGACCGAATATCTCTCCTGGCGCTCGGTGCTGCTGGTCAATGTGCCGGTCGGGATTCCCGCGGCCCTCTTCGGCCTGCGGGTCCTCGCCCGCCGGGGGGCGCCGGAGCGCGCGGTCCGGCTCGACCTGCCGGGCGCGGTCCTGGCCACGGCCGCGCTGACCCTGCTCACCTTCGGGGTCGCCCAGGCCCACACCCACGCCTGGTCCGACCCCCGCACGGCCCTGCCGCTGCTCGGCGGCGGCGCGGCCCTCGTCGCGTTCGCGGTGGTCGAGGCGCGTTTCGCCGCCACGCCCCTGATCCCGCCCCGGCTGTTCCGGCTGCCCGGGATCGGCTGGGGCAATCTGGCGATGCTGCTGGCGGGGGCGAGCCAGGTGCCGCTCTGGTACTTCCTCACCCTGACCATGCAGGACGTCCTGGGCTACAGCGCCGCGCAGACCGGACTCGGCTTCCTGCCGCACGCGGCGGTCATGCTGCTGGTCTCGCTCCGGCTCATACCGTTGCTGATGCGCCGGGTCCAGGCCAGGGTCCTCATCGCCACCGGGGCGATCGTGGAGGCGGGGGGCTTCTGGTGGCAGAGCGCCATCACCCCCGACAGCGGCTACGTCACCGGCATCCTCGGCCCGGCCGTGCTGCTCTCGCTCGGCGGCGGTCTGCTCAGCACCCCGTTGACCAGGACGGTCACCTCCGGCGTCAGCCACGCCGACGCCGGGGCCGCCTCCGGCCTGATGAACACCACCCGGCAGTTCGGCGGCGCGTTCGGCCTCGCCGTCGTTCTCACCCTCACGGCGACCGGGACCACGGGCGCGGCCGGGAGCCCCGCCGCGCTGGCGGAGAGTTACGGGGACGCCTTCCTCTCGATGGCCGTGATCCTGCTCGTCCTCGCCGCGCTCACGCCCCTGCTCCCCGCGCTGCGCGACAGCCGGTCGGGCGCCCGCCCCGGCGCCGGGGCCGGGGAGAACACCGACGGGGCCGACGGCGACACCCGCCCCGCCGTTCGCTGA	MRGSSAARTALALSCTTHFLVLFDVSVMTVALPSIQSDLGFTPSGLQWVVSAYTLAFAGLLLLGGRLADLYGHRRVFTAGLAVFTVASLLGGLATDPATLIAARAAQGLGAAVLAPLSLTMLTTSFPEGPSRTRALTIWTAVALAGGAAGNLLGGLLTEYLSWRSVLLVNVPVGIPAALFGLRVLARRGAPERAVRLDLPGAVLATAALTLLTFGVAQAHTHAWSDPRTALPLLGGGAALVAFAVVEARFAATPLIPPRLFRLPGIGWGNLAMLLAGASQVPLWYFLTLTMQDVLGYSAAQTGLGFLPHAAVMLLVSLRLIPLLMRRVQARVLIATGAIVEAGGFWWQSAITPDSGYVTGILGPAVLLSLGGGLLSTPLTRTVTSGVSHADAGAASGLMNTTRQFGGAFGLAVVLTLTATGTTGAAGSPAALAESYGDAFLSMAVILLVLAALTPLLPALRDSRSGARPGAGAGENTDGADGDTRPAVR	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	92.26	gnl|BL_ORD_ID|2188|hsp_num:0	2427			183	1410	rifampin; isoniazid
BGC0000319.1|Cephamycin_4 # 4923 # 6461 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=13bp;gc_cont=0.732	BGC0000319.1|Cephamycin_4 	4923	6461	-	Loose	700	28.1054	DHA-10	27.27	3002141	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGGTCACAGCAGCAATCAGTGGTACCGACGAGATACGCGCGAGGGCGGAGCAGGCCCTGACCCGGTGCGGAGTCGACCTCACCGCGGTCAAGGGCGACGCCCTCACGGCCCGCACCCCGCTCACCGGCGCGGATCTGTTCGGCCTGCGCGCCCACACCCCCGAGGACGTGGACCGCGCCGTCGAGGCCGCGCACACCGCGTTCCTCACCTGGCGCACCACCCCGGCCCCGGTGCGCGGCGCCCTGGTCAAGCGGTTCGGGGAACTGCTCACCGAGCACAAACAGGACCTCGCCGACCTGGTCACCATCGAGGCGGGGAAGATCCGCTCCGAGGCGCTCGGCGAAGTCCAGGAGATGATCGACATCTGCGACTTCGCGGTGGGCCTGTCCCGGCAGCTCTACGGCCGGACGATGCCCTCCGAGCGCCCCGGCCACCGGCTGATGGAGACCTGGCACCCGCTGGGCGTGGTCGGTGTGATCAGCGCCTTCAACTTCCCGGTCGCCGTCTGGGCGTGGAACGCGGCCGTGGCCCTGGTCTGCGGTGACACCGTGGTCTGGAAGCCGTCCGAGCTGACCCCGCTGACCGCGCTGGCGTGCGCCGCCCTGCTGGACCTCGCCATCGCCGACGCCGGGGCGCCGAAGGGCCTCAACCAGGTCGTCGTCGGCGCGGCCGACGTGGGCGAGCGGCTGGTTGACTCCCCCCGGGTGCCGCTGGTCAGCGCCACCGGATCGACCCGTATGGGCCGCGCCGTGGGCCCCCGGGTGGCCGCCAGGTTCGGCCGCACCATCCTGGAGCTGGGCGGCAACAACGCCGCCGTCGTGACGCCGTCCGCCGATCTCGACCTCACCGTCAACGCGGCCGTCTTCGCCGCCGCGGGCACGGCGGGCCAGCGCTGCACCACGCTCCGTCGGCTGATCGTGCACGAGGACATCGCCGACACCGTCGTCGAGCGGCTCACCGCCGCCTTCGAGCGGCTGCCGATCGGCGACCCGTTCCAGGACACCACCCTGGTCGGACCGCTGGTGAACGAGGCCGCCTTCGGCCGGATGCGGGAGGCGGTCGAGCGCGCGACCGCCGAGGGCGGCACCCTGTGCGCGGGCGGTGAGCGGCAGTTCCCCGACGCGGCGCCCGGCGCCTACTACGTACGGCCCGCGCTGGTCCGGATGCCCGCGCAGACCGCCGTGGTCCGCGAGGAGACCTTCGCGCCCATCCTGTACGTCCTCACCTACCGGGACCTGGACGAGGCCATCCGGCTGAACAACGAGGTCCCGCAGGGCCTGTCGGCAGGGATCTTCACCGCCGACCAGAGCGAGGCCGAGCGCTTCCTCGCCCCCGACGGCGCGGACTGCGGCATCGCCAACGTCAACATCGGCACCTCGGGCGCGGAGATCGGCGGCGCGTTCGGCGGCGAGAAGGAGACCGGCGGCGGCCGCGAGTCCGGCTCCGACGCCTGGCGGGCGTACATGCGCCGGGCGACCAACACGGTGAACTACTCCGGGCGGGTGGCACTGGCCCAGGGCGTGGACTTCTCCCAGTAG	MVTAAISGTDEIRARAEQALTRCGVDLTAVKGDALTARTPLTGADLFGLRAHTPEDVDRAVEAAHTAFLTWRTTPAPVRGALVKRFGELLTEHKQDLADLVTIEAGKIRSEALGEVQEMIDICDFAVGLSRQLYGRTMPSERPGHRLMETWHPLGVVGVISAFNFPVAVWAWNAAVALVCGDTVVWKPSELTPLTALACAALLDLAIADAGAPKGLNQVVVGAADVGERLVDSPRVPLVSATGSTRMGRAVGPRVAARFGRTILELGGNNAAVVTPSADLDLTVNAAVFAAAGTAGQRCTTLRRLIVHEDIADTVVERLTAAFERLPIGDPFQDTTLVGPLVNEAAFGRMREAVERATAEGGTLCAGGERQFPDAAPGAYYVRPALVRMPAQTAVVREETFAPILYVLTYRDLDEAIRLNNEVPQGLSAGIFTADQSEAERFLAPDGADCGIANVNIGTSGAEIGGAFGGEKETGGGRESGSDAWRAYMRRATNTVNYSGRVALAQGVDFSQ	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLATYTAGGLPLQVPDEVKSRADLLHFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	135.09	gnl|BL_ORD_ID|1740|hsp_num:0	1883			372	546	
BGC0000319.1|Cephamycin_5 # 6477 # 7412 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.681	BGC0000319.1|Cephamycin_5 	6477	7412	-	Loose	1900	27.7202	AcrF	28.99	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACACGACGGTGCCCACCTTCAGCCTGGCCGAACTCCAGCAGGGCCTGCACCAGGACGAGTTCCGCAGGTGTCTGAGGGACAAGGGCCTCTTCTATCTGACGGACTGCGGTCTGACCGACACCGAGCTGAAGTCGGCCAAGGACATCGTCATCGACTTCTTCGAGCACGGCAGCGAGGCGGAGAAGCGCGCCGTCACCTCGCCCGTCCCCACCATGCGCCGCGGCTTCACCGGGCTGGAGTCGGAGAGCACCGCCCAGATCACCAATACCGGCAGCTACTCCGACTACTCGATGTGCTACTCGATGGGCACCGCGGACAACCTCTTCCCGTCCGGTGACTTCGAGCGGATCTGGACCCAGTACTTCGACCGCCAGTACACCGCCTCCCGCGCGGTCGCCCGGGAGGTCCTGCGGGCGACCGGGACCGAGCCCGACGGCGGGGTCGAGGCCTTCCTCGACTGCGAGCCGCTGCTGCGGTTCCGCTACTTCCCGCAGGTCCCCGAGCACCGCAGCGCCGAGGAGCAGCCCCTGCGGATGGCGCCGCACTACGACCTGTCGATGGTCACCCTCATCCAGCAGACACCCTGCGCCAACGGCTTCGTCAGCCTCCAGGCCGAGGTCGGCGGCGCGTTCACGGACCTGCCCTACCGTCCGGACGCCGTCCTCGTCTTCTGCGGCGCCATCGCGACCCTGGTGACCGGCGGCCAGGTCAAGGCCCCCCGGCACCATGTCGCGGCCCCCCGCAGGGACCAGATAGCGGGCAGCAGCCGCACCTCCAGTGTGTTCTTCCTCCGTCCCAACGCGGACTTCACCTTCTCCGTCCCGCTGGCGCGCGAGTGCGGCTTCGATGTCAGCCTGGACGGCGAGACCGCCACGTTCCAGGATTGGATCGGGGGCAACTACGTGAACATCCGCCGCACATCCAAGGCATAG	MDTTVPTFSLAELQQGLHQDEFRRCLRDKGLFYLTDCGLTDTELKSAKDIVIDFFEHGSEAEKRAVTSPVPTMRRGFTGLESESTAQITNTGSYSDYSMCYSMGTADNLFPSGDFERIWTQYFDRQYTASRAVAREVLRATGTEPDGGVEAFLDCEPLLRFRYFPQVPEHRSAEEQPLRMAPHYDLSMVTLIQQTPCANGFVSLQAEVGGAFTDLPYRPDAVLVFCGAIATLVTGGQVKAPRHHVAAPRRDQIAGSSRTSSVFFLRPNADFTFSVPLARECGFDVSLDGETATFQDWIGGNYVNIRRTSKA	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	30.08	gnl|BL_ORD_ID|1353|hsp_num:0	1437			2070	2277	ciprofloxacin
BGC0000319.1|Cephamycin_9 # 11250 # 12206 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.696	BGC0000319.1|Cephamycin_9 	11250	12206	+	Loose	650	26.1794	otr(C)	41.46	3002894	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCGGACACGCCCGTACCGATCTTCAACCTCGCCGCACTGCGGGAAGGCGCCGATCAGGAGAAGTTCCGCGAGTGCGTGACCGGGATGGGGGTCTTCTACCTCACCGGGTACGGCGCCGGGGAGAAGGACCACCGGCTGGCCACGGACACGGCGATGGACTTCTTCGCGAACGGCACCGAGGCCGAGAAGGCGGCCGTGACCACGGACGTCCCGACCATGCGGCGCGGCTACTCCGCGCTGGAGGCCGAGAGCACCGCCCAGGTGACCAGGACCGGTTCCTACACGGACTACTCGATGTCCTTCTCCATGGGCATCTCGGGCAACGTCTTCCCCTCGCCGGAGTTCGAGCGGGTGTGGACGGAGTACTTCGACAAGCTCTACGCGGCGGCCCAGGAGACGGCGCGGCTGGTGCTGACCGCGAGCGGCGGCTATGACGCGGAGATCGTCGGAAGCCTGGACGAGCTGCTGGACGCCGACCCCGTGCTGCGGCTGCGGTACTTCCCCGAGGTGCCCGAGCACCGGTCCGCCGAGCACGAGCCGCGCCGGATGGCCCCGCACTACGACCTGTCGATCATCACCTTCATCCACCAGACGCCGTGCGCCAACGGCTTCGTCAGCCTCCAGGCCGAGATCGGCGGCGAACTGGTGAGCCTGCCCGTCGTGGAGGACGCCGTCGTCGTGATGTGCGGCGCGATGGCCCCGCTGGCGACCCAGGGCGCGCTGCCCGCGCCCCGGCACCACGTCCGGTCCCCCGGCGCCGGTATGCGCGAGGGCAGCGACCGCACGTCGAGCGTCTTCTTCCTGCGCCCCACGACCGACTTCTCGTTCTCGGTGGCCAAGGCCCGCAGCTACGGCCTCGCCGTCGACCTCGACATGGAGACGGCCACCTTCGGCGACTGGATCGGCACCAACTACGTCACCATGCACGCGAAGAACGAGCCGCAGGCCGGATGA	MADTPVPIFNLAALREGADQEKFRECVTGMGVFYLTGYGAGEKDHRLATDTAMDFFANGTEAEKAAVTTDVPTMRRGYSALEAESTAQVTRTGSYTDYSMSFSMGISGNVFPSPEFERVWTEYFDKLYAAAQETARLVLTASGGYDAEIVGSLDELLDADPVLRLRYFPEVPEHRSAEHEPRRMAPHYDLSIITFIHQTPCANGFVSLQAEIGGELVSLPVVEDAVVVMCGAMAPLATQGALPAPRHHVRSPGAGMREGSDRTSSVFFLRPTTDFSFSVAKARSYGLAVDLDMETATFGDWIGTNYVTMHAKNEPQAG	MTRKTISNGARNAVEVRGLVKHFGEVKAVDGVDLDVREGTVLGVLGPXGAAXXRGALPAHVXGPDAGRRPWRFXTWCANRRALRRTIGXHRPVRXGRRESFSGRENLYMIGRXLDLSRKDARARADELLERFSLTEAAGRAAAKYSGGMRRRLDLAASMIGRPAVLYLDEPTTGLDPRTRNEVWDEVRSMVRDGATVLLTTQYMEEAEQLAHELTVIDRGRVIADGKVDELKTKVGGRTLQIRPAHAAELDRMVGAIAQAGLDGIAGATADHEDGVVNVPIVSDEQLSAVVGMLGERGFTISGHQHPSAQLXEVFLAITGQKTSEAADGGPQDGPQDQQGVQDKQYEEVPA	90.60	gnl|BL_ORD_ID|1952|hsp_num:0	1991			93	207	tetracycline
BGC0000319.1|Cephamycin_10 # 12282 # 13847 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.692	BGC0000319.1|Cephamycin_10 	12282	13847	+	Loose	1100	27.335	mecR1	36.67	3000215	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGCTCGTCGTTGCATTCAAGCCGGGACATGACGGAGCGGTCGCCGCGATCGACGACCGCCGGCTGCTCTACTCGCTGGAGTCGGAGAAGGACTCCCGGCCGCGCTACTCGACGCTGCTGCCGACGACCTTCCTCGACATCGCCGAACGCCTCGGCGCGATCCCGGACGTCGTGGCGCTCGGCGGCTGGGCCGACCTGCGTCCGCGCGGTGTCGTGTACACGGGCGCCGGATACGAGGGCACCCAGGAACCCACCGTCACCACCTCGCGCTTCTTCGGCAAGGAGGTGAAGTTCTTCACCTCCACGCACGAGCGCTCGCACATCTACATGGCGCTGGGCATGGCCCCGAAGGACGGCGCCCCGCTGAAGAGCGTGCTCGTCTGGGAGGGGGACGTGGGCGCGTTCTACCTCGTCGACTCCGAGCACCGGATCATCCGGACGATTCCGGTGATGACGGGACCCGGGGCGCGCTACTCCTTCCTCTTCGGGCTCGCCGACCCGACCTTCCCGGACACCGGCGGCAAGCCGCGGCTGAACGACGCGGGCAAGCTGATGGCCCTGGCGGCGTTCGGCGACTCGGCCGACGCGAGCCCCGACATCCGGCATGTCGTCGAGCGCGTCCTGAAGCAGGACTCCATGTATCCGGCGCCGAAGGCCGAGTACCGGGACTCCGTGCTGCACAACGCGGGCGTCGAGTCGGAGGAGTGCAAGATCGCCGCCGCGTTGCTGACCGAGCGGCTCTTCGAGACCTTCGCGGAGGTCGCCCGGCGCGAACTGCCCGAGGGCACCCCCCTCTACATCTCCGGCGGCTGCGGGCTGAACTGCGACTGGAACAGCCAGTGGGCCCAGCTCGGCCACTTCTCCTCGGTCTTCGTGGCGCCCTGCACCAATGACTCGGGCTCGGCGCTGGGCACCGCGATCGACGCGCTCACCACGTTCACGGGCGACCCCCATATCGACTGGAACGTCTACAGCGGTCTGGAGTTCGTCCACGACACCCGGCCCGACCCGGCCCGCTGGGAATCCGTCCCGCTCGACCACGCCGCGCTGTCCTCGGCGCTCGCGGCCGGGCGGGTCGTCGCCTGGGTGCAGGGCCGCTGGGAGATCGGCCCGCGCGCGCTGGGCAACCGGTCCCTGCTGGCCGAGGCGTTCAGCTCGGCCAGCCGCGACCGGCTCAACACCGTCAAGATGCGGGAGGACTACCGGCCCATCGCCCCGGTCTGCCGGGTCGAGGACCTGGGGAAGGTCTTCCACGAGGACTTCGAGGACCCGCACATGCTGTACTTCCGGCGGGTCCGGGAGGAGAGCGGGGTACGGGCCGTGACCCATGTGGACGGCTCGGCGCGCTGTCAGACCGTCACCGGGACGAGCAATCCCGAGCTGCACCGGCTGCTGTCGGTGTTCGCCCAGGGGCAGGGCCTCGGTGTCCTGTGCAACACCTCGCTGAACTTCAACGGCGACGGGTTCATCAACCGGATGTCCGACCTCGTTCGTTACTGCGAATGGCGCGAAATTCAGGACATGGTCGTCGGGGACACCTGGTACCGGCGAATAGCCGGTTCCTGA	MLVVAFKPGHDGAVAAIDDRRLLYSLESEKDSRPRYSTLLPTTFLDIAERLGAIPDVVALGGWADLRPRGVVYTGAGYEGTQEPTVTTSRFFGKEVKFFTSTHERSHIYMALGMAPKDGAPLKSVLVWEGDVGAFYLVDSEHRIIRTIPVMTGPGARYSFLFGLADPTFPDTGGKPRLNDAGKLMALAAFGDSADASPDIRHVVERVLKQDSMYPAPKAEYRDSVLHNAGVESEECKIAAALLTERLFETFAEVARRELPEGTPLYISGGCGLNCDWNSQWAQLGHFSSVFVAPCTNDSGSALGTAIDALTTFTGDPHIDWNVYSGLEFVHDTRPDPARWESVPLDHAALSSALAAGRVVAWVQGRWEIGPRALGNRSLLAEAFSSASRDRLNTVKMREDYRPIAPVCRVEDLGKVFHEDFEDPHMLYFRRVREESGVRAVTHVDGSARCQTVTGTSNPELHRLLSVFAQGQGLGVLCNTSLNFNGDGFINRMSDLVRYCEWREIQDMVVGDTWYRRIAGS	MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNFTFSKDMMNRNVSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQIDVIKSSSLESSYLNERLKVCQSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEYIILHELSHVKSHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILKCSILKSQHINNVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQDKYETNVSYKKLNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLNHTEQQWDKHQYPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNESSLKISAIEQVNLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETKDNTYYFATHLKGEDNANGEKAQQISERILKEMELI	89.06	gnl|BL_ORD_ID|586|hsp_num:0	645			1074	1164	methicillin
BGC0000319.1|Cephamycin_11 # 14763 # 15551 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.684	BGC0000319.1|Cephamycin_11 	14763	15551	+	Loose	700	24.6386	FOX-13	26.47	3006471	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	ATGAACACCTGGAATGATGTGACGATCCGGCTCCTGGGGCCGGTGACACTCGTGAAAGGTTCCGTACCGATACCCATCCGCGGGCAGCGACAGCGGCGATTCCTCGCCTCATTAGCGCTGCGACCGGGCCAGGTCATCTCCAAGGAAGCGATCATCGAAGACTCCTGGGACGGGGAGCCACCACTGACCGTTTCGGGCCAGTTGCAGACGTCGGCCTGGATGATCCGGACCGCGCTGGCGGAGGCGGGGCTGCCCCGCGACGCCCTCGGCTCCCACGACCGCGGCTACGAACTGCGCGTCCTGCCGGACTCCATCGACCTCTTCGTCTTCCGGGAGGCCGTGCGCGCCGTGCGGGACCTGCACGCACGCGGTCAGCACCAGGAGGCGTCCGAACGGCTCGACACGGCGCTCGCCCTGTGGAAGGGGCCCGCCTTCGCGGATGTGACCTCCAGTCGGCTGCGGCTGCGGGGCGAGACCCTGGAGGAGGAGCGGACCGCCGCGGTCGAGCTGCGCGCCCTGATCGATGTCGGCCTCGGCTACTACGGGGACGCGATCACCCGGCTGTCGGAGCTCGTCGATCACGACCCGTTCCGTGAGGACCTGTATGTGAGCCTGATGAAGGCCTACTACGCGGAGGGCCGCCAGGCCGACGCGATCCAGGTCTTCCACCGCGCGAAGGACATCCTGCGGGAGCAGATCGGCATCAGCCCCGGCGAGCGGATGACAAGGGTCATGCAGGCCATCCTGCGTCAGGACGAGCAGGTCCTGCGGGTCGGTACCCCGGCCTGA	MNTWNDVTIRLLGPVTLVKGSVPIPIRGQRQRRFLASLALRPGQVISKEAIIEDSWDGEPPLTVSGQLQTSAWMIRTALAEAGLPRDALGSHDRGYELRVLPDSIDLFVFREAVRAVRDLHARGQHQEASERLDTALALWKGPAFADVTSSRLRLRGETLEEERTAAVELRALIDVGLGYYGDAITRLSELVDHDPFREDLYVSLMKAYYAEGRQADAIQVFHRAKDILREQIGISPGERMTRVMQAILRQDEQVLRVGTPA	MQQRRAFALLTLGSLLLAPCTYAGGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVNEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHGPWLKGSALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYQSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAAVKSAIALTHTGFYSVGEMTQGLGWESYAYPVTEQTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLNE	68.59	gnl|BL_ORD_ID|3534|hsp_num:0	4603			735	837	
BGC0000319.1|Cephamycin_12 # 15874 # 16890 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.721	BGC0000319.1|Cephamycin_12 	15874	16890	+	Loose	600	28.8758	CAR-1	47.37	3006903	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CAR beta-lactamase	GTGGCCGGGCGGCGGCGGACGGTACTCAAAGGGGCCCTGGCGGCATCCGGTGCGGCGGCGGTCGGGGCAGGGCTCGGTGTCGGCCTCGCCGGCGCCGACGCGCCCGCCCGCCGCGGGGGCTCCTTCTCCACCCGGGTGCGGCTGCGCTGGCTGGGGGTCTCCGGCTGGGAGATCGTCATCGACGGCGGGCACAGCATTCTGTTTGACCCGTATCTGAGCCGGATGCCCTGCCGGAATCCGCGGACGGGCGCGCTCGATTCACGGCTGCCCCTGCGGACCGACCGGTCCCTGGTGGAGGCGACGGCCGCGCGCCATCTCACCGTTCCGCCCGAGTTGATCCTGATCAGCCATGGCCATTTCGACCATATGGCCGATGTCCCGCAGTTGTTGGCCCGTCCGGCGTGGCGGCGGCGGCGCATCCGGACCGTGTGCGACGAGACGGTGCTGCATCTGCTGCTGGCGCTCGACGCGCCCCGGCCCCGGATCGACGACGTCATCCAGGTGAAGGGCGGCGAGTATCTGCGCTTCGACGGCTACACGGTGGAGGTCTTCCGCAGTCTGCACAGCCGGCTGCCGGACCACGGCTCCTTCGCCCCGGGGCGGCGGGTGTCCCCGCCGCGGCGGCCGTCCGCCCTGGGCGATCTGGTCGAGGGCGACACCCTCGCCTACCAGGTCTCCGTCGACGGCGGGCCCACGATCCTGCTGATGGGCGCGGGGAACTTCGTCGAACGCGAACTGGCCGGAATCCGGCCCGATGTCGCGCTCGTCCCCATGACGTCGCACACGGCGGTGCACCGCTATGTCGAGCGGCTGCTGACGGCAACGGGAAATCCGCCGCTGCTGATCCCCAGTCACCACGACGACATGACCACGCCGCTCACCCGTGCGCCTCGGGCGCTCGCCGACTCGGTCCGGCCGATGGCGGCACGGGAGCTGTCCCGGGCCGCCGCAGCGCGATCACGCGTGATCGAACCGCATCACCTGGGTGTGCTGGATCTCACCGCCGCACTGTCCTGA	MAGRRRTVLKGALAASGAAAVGAGLGVGLAGADAPARRGGSFSTRVRLRWLGVSGWEIVIDGGHSILFDPYLSRMPCRNPRTGALDSRLPLRTDRSLVEATAARHLTVPPELILISHGHFDHMADVPQLLARPAWRRRRIRTVCDETVLHLLLALDAPRPRIDDVIQVKGGEYLRFDGYTVEVFRSLHSRLPDHGSFAPGRRVSPPRRPSALGDLVEGDTLAYQVSVDGGPTILLMGAGNFVERELAGIRPDVALVPMTSHTAVHRYVERLLTATGNPPLLIPSHHDDMTTPLTRAPRALADSVRPMAARELSRAAAARSRVIEPHHLGVLDLTAALS	MKNQRLTPLAAFLLLISVAATAHTLPSQGTETKGAETNSPAITSLTGCGPSSAINQFFNQFGSSGKMPAELGRWLNDAKAQAVEPYQVFDNVYYVGICWVSAWLIKTSEGPVLIDTLYGEFTDQLMDNIKKIGVEPSDIKMVLLTHGHFDHVGGVSKLKSLTNARFVMSEEGWKEAQADAKKTLGKPSAWAMPDPATTDILVKDGDALTVGDTTFHAYITPGHTWGTTSYVLDVKERNNTYHAITIGGLGLNAIDGPQQVEAYIRSIDRIKVMVEDSKHPITVHLTAHPFSNGQIEMQNQLKVHQPDQPHPMVDAKGLLKQLATLRAGAIERLAVEQARIQK	98.83	gnl|BL_ORD_ID|3339|hsp_num:0	4408			417	474	
BGC0000319.1|Cephamycin_13 # 17237 # 17785 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.667	BGC0000319.1|Cephamycin_13 	17237	17785	+	Loose	500	24.6386	APH(3')-IIb	37.93	3002645	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGGTGAAGAAGACATGGAGGTCCGCGCTCGCGCTGACCGCGGCCGCCGGAGCCGTCCTCGCCACGGCCACCAGCGCCCACGCGTACACGGGCTTCACGCCCGAGCGGTACAACAAGATCCAGTTCGGGATGGACCGGACCCTGGTCTGGCAGCTCGCCGGTGCCGACCAGTCCTGCTCGGACCAAGTGGAGCGGATCATCTGCTACAACAACCCGGACCACTACGGGCCGCAGGGCCACTTCTTCTTCAACGCCGCGGACAAGCTCATCCACAAGCGGCAGATGGAGCTGTTCCCCGCGCCGAAGCCGACCATGCGGCTGGCCACCTACAACAAGACCCAGACGGGCATGACGGAGGCCCAGTTCTGGGCGGCCGTCCCCTCGGACACCTGCTCGGCGCTGGCCGAGCAGTACCCGAACTGGCCCGCCACGAACGGCAATCTGCGGGAGTACGTCTGCCCCAGCAAGGCCGAGCGGTTCGCGCCGAGCGCCTATTTCACCTTCACCGATGGCAAGCTGACCAGCAGGTCGCAGAGCCAACTGCCCTGA	MVKKTWRSALALTAAAGAVLATATSAHAYTGFTPERYNKIQFGMDRTLVWQLAGADQSCSDQVERIICYNNPDHYGPQGHFFFNAADKLIHKRQMELFPAPKPTMRLATYNKTQTGMTEAQFWAAVPSDTCSALAEQYPNWPATNGNLREYVCPSKAERFAPSAYFTFTDGKLTSRSQSQLP	MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAELPAEIARLRWLHGAGIDCPQVLNETQSDGRQWLLMSAMPGDTLSALAQRDELEPERLVRLVAAALRRLHDLDPAACPFDHRLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPNLLAEGRRFSGFIDCGRLGVADRHQDLALAARDIEAELGAAWAEAFLVEYGGDIDGERLAYFRLLDEFF	67.91	gnl|BL_ORD_ID|875|hsp_num:0	954			240	327	neomycin; ribostamycin; butirosin; kanamycin A; gentamicin B; paromomycin; gentamicin
BGC0000319.1|Cephamycin_15 # 18481 # 19764 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.702	BGC0000319.1|Cephamycin_15 	18481	19764	+	Loose	550	25.409	APH(2'')-IIa	34.62	3002635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(2'')	ATGCTCGTCGACGGGTACGACCTCGTTCTCGACCTCGACGCCAGCTCCGGCGTCTGGCTCGTCGACGCCGTCACCCAGAAGCGGTATCTCGACCTCTTTTCCTTCTTTGCCTCGGCGCCGCTCGGAATCAACCCGCCCAGCATTGTCGAGGACCCGGCATTCATGCGGGAGCTGGCCGTGGCCGCGGTCAACAAGCCGTCGAACCCCGATCTTTATTCGGTGCCGTACGCCCGTTTCGTCAAGACCTTCGCCCGGGTCCTCGGCGACCCCCGGCTGCCGCGGCTGTTCTTCGTGGACGGCGGGGCGCTGGCCGTGGAGAACGCGCTCAAGGCGGCCCTCGACTGGAAGGCCCAGAAGCTGGGCCTCGCCGAGCCGGACACCGACCGGCTCCAGGTGCTGCATCTGGAGCGCTCGTTCCACGGCCGCAGCGGCTACACCATGTCGCTGACGAACACCGAGCCGTCCAAGACCGCCCGCTTCCCCAAGTTCGGCTGGCCACGGATCTCGTCCCCCGCCCTCCAGCACCCGCCGGCCGAGCACACCGGCGCCAACCAGGAGGCCGAGCGACGGGCGCTGGAGGCCGCCCGGGAGGCGTTCGCAGCGGCGGACGGCATGATCGCCTGCTTCATCGCGGAGCCCATCCAGGGCGAGGGCGGCGACAACCACCTCAGCGCGGAGTTCCTCCAGGCCATGCAGCGGCTCTGCCACGAGAACGACGCCCTGTTCGTCCTGGACGAGGTGCAGAGCGGCTGCGGCATCACCGGTACCGCCTGGGCCTACCAGCAGCTCGGCCTCCAGCCCGACCTGGTGGCCTTCGGCAAGAAGACCCAGGTCTGCGGGGTGATGGGCGGCGGCCGGATCGACGAGGTCCCCGAGAACGTCTTCGCCGTCTCCTCCCGGATCAGCTCCACCTGGGGCGGCAACCTCGCCGACATGGTCCGCGCCACCCGGCTGCTGGAGACGATCGAGCGCACCCAGGTCTTCGACACCGTCGTCCAGCGCGGCAAGTACTTCCGGGACGGCCTGGAGGACCTGGCCGCCCGCCACCCCTCCGTCGTGACCAACGCCCGCGGCCGGGGCCTGATGTGCGCGGTCGACCTGCCGGACACCCGGACCCGCAATGAGGTGCTGCGGCTCATGTACACGGAGCACCAGGTCATCGCCCTGCCCTGCGGCGGGCGCAGCCTCCGGTTCCGCCCCGCGCTGACGATCGCCGAGCACGAGATCGACCAGGCCCTTCAGGCGCTGGCGAGCAGTGTCACGGCGGTCGCCGAGAGCGTCTGA	MLVDGYDLVLDLDASSGVWLVDAVTQKRYLDLFSFFASAPLGINPPSIVEDPAFMRELAVAAVNKPSNPDLYSVPYARFVKTFARVLGDPRLPRLFFVDGGALAVENALKAALDWKAQKLGLAEPDTDRLQVLHLERSFHGRSGYTMSLTNTEPSKTARFPKFGWPRISSPALQHPPAEHTGANQEAERRALEAAREAFAAADGMIACFIAEPIQGEGGDNHLSAEFLQAMQRLCHENDALFVLDEVQSGCGITGTAWAYQQLGLQPDLVAFGKKTQVCGVMGGGRIDEVPENVFAVSSRISSTWGGNLADMVRATRLLETIERTQVFDTVVQRGKYFRDGLEDLAARHPSVVTNARGRGLMCAVDLPDTRTRNEVLRLMYTEHQVIALPCGGRSLRFRPALTIAEHEIDQALQALASSVTAVAESV	MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF	142.81	gnl|BL_ORD_ID|1476|hsp_num:0	1615			150	228	plazomicin
BGC0000319.1|Cephamycin_16 # 20001 # 31262 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=15bp;gc_cont=0.720	BGC0000319.1|Cephamycin_16 	20001	31262	+	Loose	1000	120.939	almE	26.5	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTGCTGAAGGACGAGTGGCGCAACAGGATCGCGGTACGGGACGACGACCCCGGTGTCCGTGCGACGAGGCAGCGGGACATCGTCGTCGACGGGCGGGAGTACACCGCTCTGAAGGACGCGCTGCGCGCCGCCGACGGGGTCTCGGCGGGCGCGCTCGCGCTGGCCTCCCTGCACAGCGTGATGCGCGCGTACGGCCATGGCGAGCAGACGGTGGCGGCGTTCGTCGACGCGACGGCGACGGCGGAGCTGAAGACGGCCGCCGTGCTGCCGGTGATCGTCGACCATATCGAGCACACCCGGCTGACCTGCGCCGAGGCGATCCGGGAGCTGGACGAGACGCTGCGCCGCAAGGACTCCTACACCCGTGCGGACGAGGTGCTCCAGCGGGGGCTCTTCGATGCCCTGCTGGTGCTCGCCGAGCGCGAGGTGGCCCTGTCCGAGCTGCCGTCGGCCCCGCTGGTCATGGTCGTCCGGGACGACGCGGCCCGGGGCCGGCTGTGCTGGACGATGGCGTACGCGGGCGAGCTGTTCGAGGACACGACGGTCGCCGGTGTGCTGGAGGTCGTCCGGGAGGTGCTCGGGCAGTACGCCGGGCGGCCGGGCGACCGGGTCGCCGAGATCGAGCTGGCCTCGCGGGAGCAGCGCGAGCGGCTTCAGCGGTGGAACGCGACCGATGGCGACTTCCCGGCGGACCAGCGCCTCAACGACCTGGTCGAGGCGGCCGTGCGGCGGTCGCCGGACCGTGAGGCGGTCGTCTTCGGGACACAGCGGCTGACCTATCGGGAGGTCGACGCGCGGGCGAACCGGTTCGCGCACTGGCTGCTCGGTCCGGGTCTCGGGGTCCGTTCGCAGCAGCTCGTCGGGATCTTTCTGGACAAGAGCGATCTCGGGGTGGTCGCCACGCTCGGCATCTGGAAGGCGGGCGCGGCCTATGTGCCGATCGACCCGGCCTATCCGGCGGAGCGGGTGCGGTTCGCGGTCGGTGACACCGGGCTGCGGGGCATCGTCACCAACCGGCACCACGCGGGGCGGCTGCGGGAGATCCTGGGCGCGGAGCACGCGGATGTGACGGTCGTCGAGATCGAGTCCGTGCTCGACGAGCAGGCCGCCGCCGACACCGACGGCCTGCTGAGTGTGAAGCCCGAGCTGGCGCTGGGGGTACGGGATCTGGCCTATCTCACCTACACCTCCGGCACCACCGGTGTGCCGAAGGGGGTGCCCAAGTACCACGACAGTGTCGTGAACAGCATCACGGACCTGTCGGAGCGGTACGACATGCGGCGGCCGGGCACGGAGCGGGTCGCGCTCTTCGCCTCGTACGTCTTCGAGCCGCATCTGCGGCAGACGCTGATCGCGCTCATCAACGGGCAGACGCTGGTCGTCGTCCCCGAGGAGGTCCGGCTCGACCCGGACCGCTTCCCCGCGTACATCGAGGAGCACGGCGTCACGTACCTCAACGCGACGGGTTCGGTGCTGCAACACTTCGATCTGCGCCGATGTACCAGCCTGAAACGGCTGTTGCTGGTCGGCGAGGAGCTGACGGCGGCCGGGCTGCGCCAGCTCCGCGAGCGGTTCTCCGGGCGGATCGTCAACGAGTACGCCTTCACCGAGGCGGCGTTCGTCACCGCCGTGAAGGAGTTCGCGCCGGGCGTCACCGAGCGCGCGGACCGCAGCATCGGCCGACCGGTGCGGAATGTGAAGTGGTATGTCCTCAGCCAGGATCTGAAGCGGTTGCCGGTCGGGGCGATCGGCGAGCTGTACATCGGCGGCTGCGGGGTGGCGCCGGGCTATCTGAACCGCGACGACCTGACGGCCGAGCGGTTCCTGACCAATCCGTACGCCTCGGAGCAGGACCGGGCGCGCGGGATGAACGCCCGGATCTACCGGACCGGTGACCTGGCGCGGATGCTGCCGTCCGGCGAGGTCGAGTTCATGGGCCGCAGCGACTTCCAGCTCAAGCTGAACGGTGTCCGGGTGGAGCCGGGCGAGATCGAGGCGCAGGCCACCGAGTATGCGGGGGTCCGCAAGTGCGTGGTCATCGCCCGTGAGGGGGCGGGCGGCGGCAGCGACCGCCATCTGGTCGGCTACTACCTGACGGAGCCCGGGGCCGGGGTGACCGAGGCGGAGCTGCTGTCCTTCCTGGAGCGGCGGCTCATCCGGATCATGGTCCCGGCGCGGATGGTCCGGCTGGAGAGCATCCCCGTCAATGTCAACGGCAAGGTCGACTGGCGGGCGCTGCCCGAGGTGGACCTCGCCCGCCCGGACACGGGCGGCGGCGCGGTGGGCTCCACCACGACCGGGGGTGTCCGGGGTGAGCTGCGCGAGATCTGGAGCGCGGTCCTCGGCCTTCCGGTGTCCCGTATCGGCGACGGCGACGACTTCTTCCGGCTCGGCGGCCAGAGCATCTCCTGCATTCTGCTCATCGCCCGGATACGGCAGCGGCTGGGCGTCTTCGTCGGGGTCGAGGACGTCTTCACGCTGAGGACGCTGGGCGCGCTGGCGGACCGGCTGGAGCGCGACCGGGGCACGGCGCCCGCGGACGGCACGCCGCAGGAGCGGCGGTCCGCCGAGGGCACAGCGGACACGACGGGCACGGACGGTGCGGAGGGCGCGGACGGCGGGCCCGTGCGGCTGCTCGCGAACGGTCTCCAGCAGGGGCTGCTCTACCACGCCCTGAAGCGCCGCAACGGCGACGACGCCTATGTGATGCAGTCGGTGCACCACTACCGCTGCGCCATCCGCCCCGAGCTGATGCGCGAGGCGTGGCAGCACGCGCGGCGCACGTACCCCGCGCTGCGGCTGCGTTTCGAGTGGGCCGAGGAGGCCCTCCAGATCGTCGAGAACGACGACCGTTCCGTGGACTGGCGGTTCACCGATCTGAGCGGGGTGGCCGACCCGGCGGAGCAGGACGCCCGGATCCGGGAGCTCCAGGAGCGGGACCGGACCGAGCCCTACGACCCGGCGGCGGGCGGGCTGTTCCGGATCTATCTGATCCGCCGGAGCGAAGAGTTCTTCTCGCTGCTGTTCAGCTGCCACCACATCATCCTGGACGGCTGGAGCCTGCCGGTCCTCCACGACGACGTGCACCGGACCTATCTGCGGCTGGTGGACGGCGAGCCGGTCACGGCGGACGCGGGGAGCACCGGTACCCCCGGGAGCACCGGGAACACCGGGAACACCGGGAAGACGGACACCGCGTACATCGCGGCGCAGCGGGACTGGGAGGCGCACCGCGGCGACCACGTCGACTACTGGACCCGTCAGATCGAGCGGATCGACGAGCGGGGCGACTTCGGCGGGCTGGTCCGGGAGGACATCCGCTACCAGGTGGCGCTGAGCGAGTACGACCACGTCAAGGAGCACCGGACCCGGCGGCTCGCCCTCGGTGCCGAGCGGACCGCGGCGCTGAAGGCGGTCTGCGCGGAGCACTCCGTGACCCTGCACTCGGTGCTCCAGTTCGTGTGGCACAAGGTGCTGTACGCCGTCGGCGGCGGGAACACCACGGTGGTCGGCACGATCGTGTCCGGGCGCAATCCGCACATCGACGGGATCGAGAACTCCGTCGGTCTGTTCATCAACACGCTGCCCGTGATCGTCGACCACGACGAGCAGGCGGCGCTGGGCACGGACGCGGCCATCGCGGACATCCAGTCCGCCGTGACCGCCATGGCCGCCCGGAGCACGGTGGAGCTGGGCCGGCTGGAGACCGGCGGGATGAAGCGCCGCCTCTTCGACACCCTGCTGGTCCTGGAGAACTATCCGCGGCTGCTCTCCGAGGACGAGGAGCGCGCCCACGACGAGTTGCTGCGCTTCGAGAAGGCGTACGACGCCGACAAGGTCGACTATCCGCTGGCCGTGGTCGCCCGCGAGGAGGGTGAGGAGCTGACCGTCACCCTCTGGTACGCGGGTGAGCTGTTCGAGGACGCCACGATCGACACCCTGCTCGGGGTGGCGGAGACCCTGTTCGACCAGGTGGCCGAGGACATCTCGCGCCGGGTGGACCGGCTGGAGCTGGTCTCGCCCGCGATGGTCGAGCAGTACGGGGTGTGGAACCGGACCACGGCCCCGTTCCCGGCCGGGCAGACCCTGCACGGGGTCTTCGAGCGGCAGGCCGCCGCCTGGCCGGACGAGACCGCGGTGGTCTTCCGCGACCGGCGGCTGACCTACCGGGAGCTGAACGAGCGCGCCAACCGGCTGGCGCACCATCTGCGCTCGGTCGCGGAGCTGCGCCCGAACGACCTGGTCGGCCTGGTCGTCGACAAGAACGAGCTGATGATCACCGCGATCCTGGCGGTGTGGAAGACGGGCGCGGGCTATGTCCCGATCGACCCGGGCTACCCCGACGACCGGGTGGCGTTCATGCTGGCGGACACCAGCGCCAAGCTGGTGATCACCAACCAGGGGCGGGTGGCGCGGATCGGGGAGCTGACCGGTGGCGCGCTGCCGGTGGTGGATCTCGACCGGCTGCCCGACGGCAACGGCGCGGACGGCGACCCGGTCACCGATGTCACCGCCACGGATCTCGCGTACGCGATCTACACCTCCGGCACCACCGGCAGGCCCAAGGCGGTGCTGGTCGAGCACCGGGGTGTGGTGAACCTCCAGCACTCGCTGGCGAAGCTGTTCGGCCTGGACCGGAGCGAGGGCGTCGAGGCGCTGCTGTCGTTCTCGAACTACGTCTTCGACCACTTCGTGGAGCAGATGACGGACGCCCTGCTCAACGGGCAGAAGCTGGTCGTCCTCGACGACACCATGCGCACGGACGCCGAGCGGCTGTACCGGTACATCAACGACGAGCAGGTCACCTATCTCTCCGGCACGCCGTCGGTGCTCTCGCTCTACGACTACTCGACGACGACCTCGCTGACCCGGATCGACGCGATCGGCGAGGACTTCACCGAGCCGGTCTTCAACAAGATCCGCGCCATGTTCCCGGGGACGATCATCAACGGGTACGGGCCGACGGAGATCTCGATCACCAGCCACAAGCGGCCCTACACGGTCGGCGAGCGGCGGTCGACGAAGAGCATCGGCCACCCGGTGGACAACTACACGGCCTATGTCCTGAACAAGTCGATGCAGCGGGTGCCGGTCGGCGGCATGGGCGAGCTGTACATCGGCGGTGTCGGCGTCACCCGCGGCTATCTGAACCGCGACGAGCTGACGGCGGACCGCTTCGTCGACAACCCCTTCCAGACCGCCGAGGAGCGGGCCGAGGGGCGCAACGCGCGCGTCTACAAGACCGGTGACCTGGTGCGCTGGCTGCCCAACGGCGAGCTGGAGTGCCTGGGCCGCACCGACCTCCAGGTCAAGATCCGGGGACAGCGGGTCGAGCTGGGCGAGGTCGAGGCCGCGCTCTCCTCGTACCCGGGCGTCACCCGTTCCCTGGTCATCGCGCGGGAGCACCGGGGCGCGGGGCTCGCGTCGGCGCAGAAGTACCTCGTGGGCTTCTATGTCGGCACGGACGATCTGGACGAGCAGGACGTCAGGCAGTGGATGCGGACGAAGCTGCCCGAGGCGGTCGTCCCCTCCCGGGTGCTGCGGATCACCGACATCCCGGTGACGCCGAGCGGCAAGCTGGACGTCACACGGCTCCCGGAGACCGACTTCGGCCCGGGTGACAGCGGCGAGTACATCGCGCCGTCGAACGATGTCGAGACCAAGCTGTGCGGCATCTGGGCCACGGTGCTCGGTCTCGCCCCGGAGCGGGTCGGCGTCACCGACGACTTCTTCGCCCTCGGCGGCGACAGCCTCCGGGCGATGGTGCTGGCGCAGGCCATCACCACCGGCTTCGGCCGGGGTCTCGGGGTCGCGACCGTGCTCCAGCACACGACCCTCGGGGCGCAGGCGAAGCACATCCGCGAGAGCGCCGCGCACGGCGACGGGGAGCAGGACGGGCCGGTCGCGGGCCGGGCCGCGGCGGGCGACGGAAACCCGCCGGTGTCGCTCGCGCAGGAACGTCTGCTGTTCATCGACGAGTTCGAGGGCGGCACCGACGCCTACAACATCCCCTTCGTCCTGGAGATCGCGACCGGGGACGCCGCCTCGACCCGGGACGCGGTCACCGGGGCGCTGCGCGCCCTGCTGGGGCGGCACGCGGCGCTGCGCACCCTGCTGCGGACCGACGAGCACGGCGTCCGGCGGCAGTACCCGCTGCCCGCCGCCGAGGCCGCGGCCCGGTTCGAGGTCCCGCTGCACACGGTCGCGGACCGCACGGCCCTGGACGAGCGGCTGGTGGAGCGGTCCCGCACGGTCTTCCGGCTGGACGAGGAGCTGCCGCTCGTGGCCGACCTCTTCACGGCCGGTCCGGCGGACGGCCGCGCGTATCTGAGTCTGGTCGTCCACCACAGCGCCTTCGACGGCTGGTCGTGGAGCACCTTCCGGGAGGAGCTGGCGGCCCTGCTGCGCGGTGTCCCCGTGACGGATCTGCGGCAGGTCCACGGCAGCTACGCCGACTTCTCGCTGTGGCAGCGGCAGTATCTGTCCGGGGGCAGGCTGGCGGAGCTGACCGGGTACTGGACGGGGGCGCTGGCCGGGTACGAGACGATCCGGCTGCCGCTGGACCGCCCGCGTCCGGCGCGCTTCGACTACCGGGGCCGGGAGATCGACTTCGACCTCGACGAGGGGACGGCGCGGGCGCTGCGCGAGCTGGCGCGGTCCGCGCGGGTGAGCCTGTACAGCGTGCTGCTCGGCGCGTGGGCGCTCACCCTGCGCGTCTACACCGGCCAGGACGACTTCGTCGTGGGCACGCCCGCCGCGAACCGGGGGCGCCCGGAGTTCGACCGGACCGTCGGCTTCTTCGCGAACCTGCTGGCGCTGCGGGTCCGGGTCGACGCGGACGCCGGTCTCGCGGAGTACATCCGCGCGGTCGGCGCGGACGTGGTCGCGGCCCAGGTCCACGGCGAGCTGCCGTTCGAGCAGCTCGTGAAGGAGCTGAACCCGGAGAAGGACCCGAGCCGGCACCCCGTGCTCCAGGTCAACTTCACCCTCCAGAACGTCACCGACCGCGCTCCCGTCGGCGGCGGGGCCGGGGCGGAGCCGGAGTTCACCGAGTACAAGCCGGACGCCGGGGGCTTCACGGCCACCAAGTTCGATCTGTCGGCGACGGTCACCGAGAACGCCGCGGGGCGGCTCGCGGGCAACCTCACCTACGCCGCCGCGCTCTTCGACGACGACACCGCCGAAGGGTTCATCGCCACCTTCCGGCAGGTCCTCGCGGAGTTCGCGCGGCTCGCGGACGCCGGGGAGCAGGCCAGGGTCGCGGAGGTGGACCCGGTCGGCGCGGCGGAGCGCGCGGCCCTCGCGGCCGGTCCCGCCGGGGCCCTCCAGGCCGCGGCCGCCGAGGCGCTGCCCGCCCCCCGGACCCTGCACACGGTCTTCGAGGAGCAGGCCGCCGCCTGGCCGGACGCCGTCGCGGTCGCCCACGGCGCGACCCGGCTCACCTACCGGGAGCTGAACGAGCGCGCCAACCAGCTCGCGCACTATCTGCGCTCCGTGGCGCGGATCCGTCCGAGCGATCTGATCGGCCTGGTCGTCGAGAAGAGCGAGCTGACCGTCGTCGCGATCCTCGCGGTGTGGAAGGCGGGCGCGGGCTATCTGCCGATCGACCCGGGCCACCCCGACGACCGGGTGACCTTCATGCTGGCGGACACCGAGGCCCGGCTGGTGGTCACCCAGCGGGCCCACGGGGAGCGGCTGCGCCGCCTCGCGGGCGACGCGCTGCCGGTGGTGGAGATCGACGCGCTGCCGCAGGGCTACCGCTCGACCGACGACCCGGTCACGGACACCACCCCGGCGGACCTCGCGTACGCGATCTACACCTCGGGCACCACCGGCCGCCCCAAGGCGGTGCTGGTTCCGCACCGCGCGGTGGACAGCTTCCGCGCGACGCTGGCCGGACGGTACTTCGGCCCGCCCGACACCGGCCGCCAGGGGGTGCTGTTCCTCGCCAACTATGTCTTCGACTTCTCGGTGGAGCAGCTCGCGCTGTCCGTCCTCGGCGGTCACACCCTGATCGTCCCGCCGCCGTCGCCCGCGCAGGACGAGCGGTTCTACGAGGACGCGAACCGCGCCGGGCTGACGTACATCAGCGGGACGCCCACCCAGGTCCAGCAGTTCGACCTGGCGCGGCTGCCGGGGCTGCGCACAGTGCTGGTCGCCGGTGAGGCGTTCCACGAGCGCCACTTCGAGAAGATCCGCGAGGGCTGGGCGGGGCCGATCCTCAACGCGTACGGCACCACCGAGACGGCCGTCTACAACACCGTCCGGCGCTTCGAGCCGGGTGACCCCTACCGCAACACCCTGGGTCTGCCGCTCGGGAACACCCGGCTGTACGTCCTCGGCGACGGGCTGAAGCCGCTGCCGCCGGGCGCGGTCGGCGAGCTGTATGTGGCCGGTGAGTGTGTGACGGACGGCTATCTCAACCGGCCGGAGCTGACCGGTGAGCGCTTCCTGCCGAACCCGTTCGACACCGGGGAGGAGGGGCGGGAGGGCCGCCACCCGGTCCTCTACCGCAGTGGCGACCTGGTCCGGCTGACCCGCGGCGGCGAGCTCCAGTACCTGGGCCGCAACGACGCCCAGCTCAAGATCCGCGGGCTGCGGATCGAGCCGGGCGAGGTGGAGGCGGTCCTCGCCACCGCTCCGGGGGTCCGCGAGTGCGCGGTCGCCGCCGTGGCCGACGACCGCTCCCCGGGGAACACCCGGCTGGTCGGCTACTACGTCGCCGCCACCGGCACGGAGACGGACACGGACACCGGCACGGGCGACGCCGGGGGCGCCGACGAGGACGCGATCTTCGCGGTGCTGCGGGCGCGGCTGATGCCGGGCATGGTGCCCTCGCTGCTGATCCGCATGGACGGCCCGCTGCCGATGACCATCAACGGCAAGCTGGACACCAAGGCGCTGCCGAAGGCGGCGCTGCCGGAGCGGCGCGCGGACCGCACGGCCCCGCGCAACCGGACCGAGGCCCGGCTGTGCCAGCTCTGGGGCGACCGGCTCCCCGGTGGCACGGTCGGCATCGACGACGACTTCTTCCGCTCGGGCGGCGACAGCATCAGCGCCCTGCACCTGGCGAGCCAGGTGCAGCGGGAGATCGGGCGCAGGGTCGGCGTCAAGGACATCTTCGACCATCCGACCGTCCGGCACTTCGCCGAGCGGGTGCTGGCCGCCCCGGACCGGGGGCGGGACCCCGGCGAGGGCGGCGAGGCGCCCGAGCAGGGCCGGCTGGACGGTGACTGTCCGCTGCTGCCCATCCAGGAGTGGTTCTTCGCCAAGCCGCTCGCCGACCGGAACTGGTGGAACCACAACTTCGCCGTCACCGCCCCGGAGCTGGACGTGGCGAGGCTGGGCCAGGCGCTGGCGCGGCTGGTCGAGCACCATGACGCGTTCAGCCTGCGGTACCGCTCCGAGGGCGGCGGCGACGGCGCGGACGAGCGGTTCGTCCAGCGCTACGACGCCGCCGTGCCCGAGGTCGTCCTGCACGAGCTGGATGTGCGCGGGCTCTCCCCCGAGGAGATCTCCGAACGGCTCGCCCGCTGGCAGAGCGGCTTCGACCTGGAGCGCGGACCGATCCACTGCGCGGCCTATCTGCACGGCTTCGCCGATGGCTCGGCCCGGGTCTGGTTCGCCCTGCACCACCTGGTCGTCGACACCGTGAGCTGGCACATCCTCGCGCAGGACCTGGAGATCCTGTACCACGGGGGCGCGCTGGAGGAGAAGACGAGCAGCTACCGCCAGTGGGCGCGGGCGCTCGCCGCGTACCCGGCGGACGAGGCCGAGCGGCGGCTGTGGGCGGAGGCCGTCGCGTCCCTGGCGGCCACCGCACAGGCGCTGCCGGTCCCGGCGCCGGGCGCGGCGACGCTCCGGGAGGAGTTCGCGCTCGACGCGGAGCGGACCACGGCGCTGCTGACCGAGTGCCACTGGGCGTACGACACCACCATCAACGATCTGCTGCTGACGGCGGTCGGGGGCGCGCTGCGGGCCGTCACCGGCCTGGCGGTCAACCATGTCACCGTGGAGGGCCACGGCCGGGAGCGGTTCGACGGGGCGCCCGACGTCCGGGACACGGTGGGCTGGTTCACGACCATGCACCCGCTGGCCGTGGAGGCGCACCCGCAGGACGTGGGGCGCGGCATCACCGCCACGAAGGAGGCTTCCCGGCGGGTGCCGCACCACGGCATCGGATACGGGGCCCTCTTCGGCCGCTACGGCGGGGAGCGGGCGCCGCTGCCGCCGGTGAGCTTCAACTACCTCGGCCGGGTCTCCGACGCCGGGGAGCAGACGGACGGGCCCTCCGCGGGCTGGCGGCTCGACTCGGCGATGTCGGGGAGCAACATCTCCGGCCGCAACCGGGGCGCCGACCAGTTCAGTGTGGACGTGACCATGCGATGTACCGGCGGCCGGCTCGTCACCGCGGTGGACAGCCGACTGGACGAGGAGACCACCCGGCGCTTCACGGACGAGCTGAGGAGCTGGCTGGAGCGGCTCGTCGCCCACACCTCGGCGGTGTCGGGCGAGAACGGCGGCCGGGCGCGCGCCGCCGAGCGGGCCGGGGCCGGGACGGAGTTCGACCCGTACATCCTCGTCGACGGGGACCGCGCCGAGCGCACCCTCTTCGTCTTCCCGCCCGGTGAGGGCGGCGCCGAGAGCTATCTGAGCAATCTCGCGCAGCGGCTGCCCGGCCACCGGCTGGTGCTCTTCAACAATGTGCATCTGCACCGGCCGATGGAGTCCTTCGAGGCGCTGGCCGACTTCTATCTCCCCCTCCTCCGGGAGATCCAGCCGTCCGGCCCGTACCACCTGCTGGGCTGGAGCTTCGGCGGGGTGCTCTCGGTGGAGGTCTCGCTCCGGCTGGCCCGGGCGGGCGAGCGGATCGAGGAGCTGTTCCTCATCGACCCGTACTTCGACGTCCGGGCCTCGTCGGCGGCGATCGGGCTGCCGGAGACCGAGGACATCCTCGATCCGATCAACTACCACTGGGCGCCCGCCCGGGAGGATCTGGAGCGGCTGCGCGCGAACACCGGCGATGTGGTGCTGTTCCGGGCGGACGAGCCGAACGAGATCGTCCGGGACGAGGAGCAGCGCCGGCTGTTCGACTTCTACCAGCGGTCCTCCTTCAACGGGCTGGACGCGCTGCTGCCCGCGGAGTCCATCGAGGTCCACCGGCTGCACGGTGAGACCCACCATTCGTGGGTACGAAACGACCGGCTGGTCGCCGACATCTGTGCGCGTGTCTCGGCGTCGTCGCCGGATGCCCGGTGA	MLLKDEWRNRIAVRDDDPGVRATRQRDIVVDGREYTALKDALRAADGVSAGALALASLHSVMRAYGHGEQTVAAFVDATATAELKTAAVLPVIVDHIEHTRLTCAEAIRELDETLRRKDSYTRADEVLQRGLFDALLVLAEREVALSELPSAPLVMVVRDDAARGRLCWTMAYAGELFEDTTVAGVLEVVREVLGQYAGRPGDRVAEIELASREQRERLQRWNATDGDFPADQRLNDLVEAAVRRSPDREAVVFGTQRLTYREVDARANRFAHWLLGPGLGVRSQQLVGIFLDKSDLGVVATLGIWKAGAAYVPIDPAYPAERVRFAVGDTGLRGIVTNRHHAGRLREILGAEHADVTVVEIESVLDEQAAADTDGLLSVKPELALGVRDLAYLTYTSGTTGVPKGVPKYHDSVVNSITDLSERYDMRRPGTERVALFASYVFEPHLRQTLIALINGQTLVVVPEEVRLDPDRFPAYIEEHGVTYLNATGSVLQHFDLRRCTSLKRLLLVGEELTAAGLRQLRERFSGRIVNEYAFTEAAFVTAVKEFAPGVTERADRSIGRPVRNVKWYVLSQDLKRLPVGAIGELYIGGCGVAPGYLNRDDLTAERFLTNPYASEQDRARGMNARIYRTGDLARMLPSGEVEFMGRSDFQLKLNGVRVEPGEIEAQATEYAGVRKCVVIAREGAGGGSDRHLVGYYLTEPGAGVTEAELLSFLERRLIRIMVPARMVRLESIPVNVNGKVDWRALPEVDLARPDTGGGAVGSTTTGGVRGELREIWSAVLGLPVSRIGDGDDFFRLGGQSISCILLIARIRQRLGVFVGVEDVFTLRTLGALADRLERDRGTAPADGTPQERRSAEGTADTTGTDGAEGADGGPVRLLANGLQQGLLYHALKRRNGDDAYVMQSVHHYRCAIRPELMREAWQHARRTYPALRLRFEWAEEALQIVENDDRSVDWRFTDLSGVADPAEQDARIRELQERDRTEPYDPAAGGLFRIYLIRRSEEFFSLLFSCHHIILDGWSLPVLHDDVHRTYLRLVDGEPVTADAGSTGTPGSTGNTGNTGKTDTAYIAAQRDWEAHRGDHVDYWTRQIERIDERGDFGGLVREDIRYQVALSEYDHVKEHRTRRLALGAERTAALKAVCAEHSVTLHSVLQFVWHKVLYAVGGGNTTVVGTIVSGRNPHIDGIENSVGLFINTLPVIVDHDEQAALGTDAAIADIQSAVTAMAARSTVELGRLETGGMKRRLFDTLLVLENYPRLLSEDEERAHDELLRFEKAYDADKVDYPLAVVAREEGEELTVTLWYAGELFEDATIDTLLGVAETLFDQVAEDISRRVDRLELVSPAMVEQYGVWNRTTAPFPAGQTLHGVFERQAAAWPDETAVVFRDRRLTYRELNERANRLAHHLRSVAELRPNDLVGLVVDKNELMITAILAVWKTGAGYVPIDPGYPDDRVAFMLADTSAKLVITNQGRVARIGELTGGALPVVDLDRLPDGNGADGDPVTDVTATDLAYAIYTSGTTGRPKAVLVEHRGVVNLQHSLAKLFGLDRSEGVEALLSFSNYVFDHFVEQMTDALLNGQKLVVLDDTMRTDAERLYRYINDEQVTYLSGTPSVLSLYDYSTTTSLTRIDAIGEDFTEPVFNKIRAMFPGTIINGYGPTEISITSHKRPYTVGERRSTKSIGHPVDNYTAYVLNKSMQRVPVGGMGELYIGGVGVTRGYLNRDELTADRFVDNPFQTAEERAEGRNARVYKTGDLVRWLPNGELECLGRTDLQVKIRGQRVELGEVEAALSSYPGVTRSLVIAREHRGAGLASAQKYLVGFYVGTDDLDEQDVRQWMRTKLPEAVVPSRVLRITDIPVTPSGKLDVTRLPETDFGPGDSGEYIAPSNDVETKLCGIWATVLGLAPERVGVTDDFFALGGDSLRAMVLAQAITTGFGRGLGVATVLQHTTLGAQAKHIRESAAHGDGEQDGPVAGRAAAGDGNPPVSLAQERLLFIDEFEGGTDAYNIPFVLEIATGDAASTRDAVTGALRALLGRHAALRTLLRTDEHGVRRQYPLPAAEAAARFEVPLHTVADRTALDERLVERSRTVFRLDEELPLVADLFTAGPADGRAYLSLVVHHSAFDGWSWSTFREELAALLRGVPVTDLRQVHGSYADFSLWQRQYLSGGRLAELTGYWTGALAGYETIRLPLDRPRPARFDYRGREIDFDLDEGTARALRELARSARVSLYSVLLGAWALTLRVYTGQDDFVVGTPAANRGRPEFDRTVGFFANLLALRVRVDADAGLAEYIRAVGADVVAAQVHGELPFEQLVKELNPEKDPSRHPVLQVNFTLQNVTDRAPVGGGAGAEPEFTEYKPDAGGFTATKFDLSATVTENAAGRLAGNLTYAAALFDDDTAEGFIATFRQVLAEFARLADAGEQARVAEVDPVGAAERAALAAGPAGALQAAAAEALPAPRTLHTVFEEQAAAWPDAVAVAHGATRLTYRELNERANQLAHYLRSVARIRPSDLIGLVVEKSELTVVAILAVWKAGAGYLPIDPGHPDDRVTFMLADTEARLVVTQRAHGERLRRLAGDALPVVEIDALPQGYRSTDDPVTDTTPADLAYAIYTSGTTGRPKAVLVPHRAVDSFRATLAGRYFGPPDTGRQGVLFLANYVFDFSVEQLALSVLGGHTLIVPPPSPAQDERFYEDANRAGLTYISGTPTQVQQFDLARLPGLRTVLVAGEAFHERHFEKIREGWAGPILNAYGTTETAVYNTVRRFEPGDPYRNTLGLPLGNTRLYVLGDGLKPLPPGAVGELYVAGECVTDGYLNRPELTGERFLPNPFDTGEEGREGRHPVLYRSGDLVRLTRGGELQYLGRNDAQLKIRGLRIEPGEVEAVLATAPGVRECAVAAVADDRSPGNTRLVGYYVAATGTETDTDTGTGDAGGADEDAIFAVLRARLMPGMVPSLLIRMDGPLPMTINGKLDTKALPKAALPERRADRTAPRNRTEARLCQLWGDRLPGGTVGIDDDFFRSGGDSISALHLASQVQREIGRRVGVKDIFDHPTVRHFAERVLAAPDRGRDPGEGGEAPEQGRLDGDCPLLPIQEWFFAKPLADRNWWNHNFAVTAPELDVARLGQALARLVEHHDAFSLRYRSEGGGDGADERFVQRYDAAVPEVVLHELDVRGLSPEEISERLARWQSGFDLERGPIHCAAYLHGFADGSARVWFALHHLVVDTVSWHILAQDLEILYHGGALEEKTSSYRQWARALAAYPADEAERRLWAEAVASLAATAQALPVPAPGAATLREEFALDAERTTALLTECHWAYDTTINDLLLTAVGGALRAVTGLAVNHVTVEGHGRERFDGAPDVRDTVGWFTTMHPLAVEAHPQDVGRGITATKEASRRVPHHGIGYGALFGRYGGERAPLPPVSFNYLGRVSDAGEQTDGPSAGWRLDSAMSGSNISGRNRGADQFSVDVTMRCTGGRLVTAVDSRLDEETTRRFTDELRSWLERLVAHTSAVSGENGGRARAAERAGAGTEFDPYILVDGDRAERTLFVFPPGEGGAESYLSNLAQRLPGHRLVLFNNVHLHRPMESFEALADFYLPLLREIQPSGPYHLLGWSFGGVLSVEVSLRLARAGERIEELFLIDPYFDVRASSAAIGLPETEDILDPINYHWAPAREDLERLRANTGDVVLFRADEPNEIVRDEEQRRLFDFYQRSSFNGLDALLPAESIEVHRLHGETHHSWVRNDRLVADICARVSASSPDAR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	675.00	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000319.1|Cephamycin_17 # 31294 # 32283 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=5bp;gc_cont=0.664	BGC0000319.1|Cephamycin_17 	31294	32283	+	Loose	500	28.4906	SCO-1	33.33	3004856	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	SCO beta-lactamase	ATGCCAGTTCTGATGCCGTCGGCCCACGTTCCGACCATCGACATCTCGCCGCTGTTCGGAACCGACGCCGCCGCGAAGAAGCGCGTCGCCGAGGAGATACACGGGGCCTGCCGCGGCTCGGGCTTCTTCTACGCCACGAACCACGGCGTGGACGTCCAGCAGCTCCAGGACGTGGTGAACGAGTTCCACGGCGCCATGACCGACCAGGAGAAGCACGACCTGGCGATCCACGCGTACAACCCGGACAACCCGCATGTGCGCAACGGCTACTACAAGGCGGTCCCGGGCAGGAAGGCCGTCGAGTCCTTCTGTTACCTCAACCCGGACTTCGGCGAGGACCACCCGATGATCGCCGCGGGGACGCCGATGCACGAGGTGAACCTCTGGCCCGACGAGGAGCGGCACCCGCGCTTCCGGCCGTTCTGCGAGGGCTACTACCGGCAGATGCTGAAGCTCTCCACCGTGCTCATGCGGGGGCTGGCGCTGGCGCTCGGGAGGCCGGAGCACTTCTTCGACGCGGCGCTCGCCGAGCAGGACTCCCTGTCGTCCGTCTCGCTGATCCGCTACCCGTATCTGGAGGAGTACCCGCCGGTGAAGACGGGTCCCGACGGCCAGCTCCTGAGCTTCGAGGACCATCTGGACGTCTCGATGATCACCGTGCTCTTCCAGACCCAGGTGCAGAACCTCCAGGTGGAGACGGTCGACGGCTGGCGGGACATCCCGACGTCGGAGAACGACTTCCTGGTCAACTGCGGTACCTACATGGCGCATGTCACGAACGACTACTTCCCGGCGCCCAACCACCGGGTGAAGTTCGTGAACGCGGAGCGGCTGTCCCTGCCGTTCTTCCTCAACGGCGGGCACGAGGCGGTCATCGAGCCGTTCGTGCCGGAGGGCGCGAGCGAGGAGGTGAGGAACGAGGCCCTGTCCTACGGGGACTACCTCCAGCACGGGCTGCGGGCGCTGATCGTCAAGAACGGCCAGACCTGA	MPVLMPSAHVPTIDISPLFGTDAAAKKRVAEEIHGACRGSGFFYATNHGVDVQQLQDVVNEFHGAMTDQEKHDLAIHAYNPDNPHVRNGYYKAVPGRKAVESFCYLNPDFGEDHPMIAAGTPMHEVNLWPDEERHPRFRPFCEGYYRQMLKLSTVLMRGLALALGRPEHFFDAALAEQDSLSSVSLIRYPYLEEYPPVKTGPDGQLLSFEDHLDVSMITVLFQTQVQNLQVETVDGWRDIPTSENDFLVNCGTYMAHVTNDYFPAPNHRVKFVNAERLSLPFFLNGGHEAVIEPFVPEGASEEVRNEALSYGDYLQHGLRALIVKNGQT	MTRSALLIPLTTAAIALNAISPVYASDTHSIDDTVKQVETTLGAKVGIAVLDTGSQRAWFHRADDRFPMASTSKALTCAALLDKGQSFMNKEALIKKADLDEYAPVTSGIVGKKVSAADLCSITMRTSDNTAVNKVLEILGGPQAVTAYLRKTGDNITRLDRNEPDLNEGTPGDVRDTTTPRAILETLNKLVLGPTLGSDERKQLTTWLESNEVGDPLLRAGVPSDWRVADRTGAGGNGTRGVIAVMWPPKHAPIIAAIYITQTKATMEERNAAIASIGKAIAAEVLE	114.24	gnl|BL_ORD_ID|2627|hsp_num:0	3653			255	381	penicillin; cefepime; ceftazidime; cefuroxime; amoxicillin; piperacillin; cefotaxime; cefalotin; ticarcillin
BGC0000319.1|Cephamycin_18 # 32392 # 34047 # -1 # ID=1_18;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000319.1|Cephamycin_18 	32392	34047	-	Loose	1250	65.855	mecA	21.86	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGACGCATTCCGACAACTATGGCGATGACCCGCCGCAGGGCAGGCGCCGCTCCCGTGGCCGGGCGGCCACCGCGGTGGTCGCCGGGCTGGCCGTGACGGTGGGGCTCGGCTATTGGGGTTACACCAGCCTGGTTGCCGACGAGAAGGATTCGGGCGACCCCGAGGTGGAGGCGGCGGCCGGACAGTTCGACACCTTCCTCGGCGCCTGGGAGAAGGGCGACGCCCCGACGGCCGCCGGGCTGACGGACACCCCGGACAACGCCGAGTCGCTGATCAAATCCGTCATGACCAACCTCAAGCCGACGAAGACGGAGATCACCGCCAAGACCGGGGAGAAGAACCCCGAGGGCGAGGTGGAGATACCGTTCACCGTCAGAATGACCCTCCCCGGGGCCGGGGAGTACGCCTGGGACTCCACCGCGAAGGTCGTCGGCGGCGGCAAGGAGTGGAAGGTCGCGTTCAACACCGAGATGATCCATCCGCAGATGGTTCCGGGGCAGACCCTCGCCCTCAAGTCGCGGGAGCGCGCGGACATCCTCGACGCCAACGGCAATGTCCTCCAGGCCGCCTCCATCATCGGCGCGGTCGACCCCAGGACCGGCAAGGGCTCGGCGGGCCTCCAGTCCCGCTACGACAAGCAGCTCACCGGCGGCTCCGGCGCGGCGCGCTCGGTCGTGATCCTGGACCGTGAGTCCGGCCAGGTGGTCAAGAAGCTCACCGGCCTCAAGGACACCGAGGGCAAGCCGGTGAAGACCACCATCGACCCGCGGGTCCAGTCCGCCGCCGCGGCGGCCCTGGAGGGCTCGAAGAAGAACGCGGCGATCGTCGCCGTCGACCCCGCCACCGGCAACATCCTGGCCGCCGCGAACGTGCCCTCCGGCATGAACCGCGCGCTGGAGGGCCGCTACCCGCCCGGCTCCACCTTCAAGGTGGTCACCACCGCGGCCCTGCTCCAGCAGGGGATGAACCCGGAGGAGCGGGCCGACTGCCCGAAGTTCGCCCATGTCAACGGCCAGAGCTTCGAGAACCAGGACCAGTTCACGCTGCCCGCGGGCTCGACCTTCCGGGACAGCTTCGCCCACTCCTGCAACACGTTCTTCGTCAACTCCCGCAGCAAGCTCTCCGAGTCCAGCCTGAAGCAGGCCGCCGAAGCCTTCGGCATCGGCGGCACCTGGGACGTCGGCGCCTCCACCTTCGACGGCAGCGTCCCCGTCTCCAACAGCGAGAACGACAAGGCCGCGTCCACCATCGGACAGGCCAGGGTCGAGGCGTCGCCCCTGGTGATGGCCTCCATCGCCGCCACCGTCAAGCAGGGCGAGTTCAAGCAGCCCGTGCTGGTGCCCGACGCGGTCAAGAAGCCGCACCAGGCCCCCCGGATGGCCCCGGGCATCGTCGACTCGCTGCGTTCCATGATGCGTTCGACCGTCACCGACGGCGCCGGCGACGCCCTGCGGGGCCTCGGCGGACAGCCGCACGCCAAGACCGGTACCGCCGAGTTCGGCACCGAGAAGCCGCCGAAGACGCACGCCTGGATGATCGGCTACCAGGGCGACCGGAACATCGCCTGGTCGGTCCTGCTGGAGGACGGCGGGTCGGGCGGCGCCGACGCGGGCCCCGTCGCCGCGAAGTTCCTCAGCAACCTCGCGGCCGGCTGA	MTHSDNYGDDPPQGRRRSRGRAATAVVAGLAVTVGLGYWGYTSLVADEKDSGDPEVEAAAGQFDTFLGAWEKGDAPTAAGLTDTPDNAESLIKSVMTNLKPTKTEITAKTGEKNPEGEVEIPFTVRMTLPGAGEYAWDSTAKVVGGGKEWKVAFNTEMIHPQMVPGQTLALKSRERADILDANGNVLQAASIIGAVDPRTGKGSAGLQSRYDKQLTGGSGAARSVVILDRESGQVVKKLTGLKDTEGKPVKTTIDPRVQSAAAAALEGSKKNAAIVAVDPATGNILAAANVPSGMNRALEGRYPPGSTFKVVTTAALLQQGMNPEERADCPKFAHVNGQSFENQDQFTLPAGSTFRDSFAHSCNTFFVNSRSKLSESSLKQAAEAFGIGGTWDVGASTFDGSVPVSNSENDKAASTIGQARVEASPLVMASIAATVKQGEFKQPVLVPDAVKKPHQAPRMAPGIVDSLRSMMRSTVTDGAGDALRGLGGQPHAKTGTAEFGTEKPPKTHAWMIGYQGDRNIAWSVLLEDGGSGGADAGPVAAKFLSNLAAG	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	82.49	gnl|BL_ORD_ID|1216|hsp_num:0	1321			834	1905	methicillin
